BIOMARIN PHARMACEUTICAL INC Other Comprehensive Income (Loss), Tax
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Comprehensive Income (Loss), Tax of -$186.00 thousand for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2016-08-08
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for the quarter ending 2016-06-30 was -$186.00K.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for the quarter ending 2016-03-31 was -$2.79M, a 167.12% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for the quarter ending 2015-09-30 was -$2.96M, a 156.66% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for the quarter ending 2015-06-30 was -$1.98M, a 230.29% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for fiscal 2014 was $3.78M, a 39.07% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for fiscal 2013 was $2.72M.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for fiscal 2011 was $3.10M, a 675.00% increase from fiscal 2010.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), tax for fiscal 2010 was $400.00K.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 3 month as first filed | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 6 month as first filed | Other Comprehensive Income (Loss), Tax 9 month | Other Comprehensive Income (Loss), Tax 9 month as first filed | Other Comprehensive Income (Loss), Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2016-06-30 | -$186.00K 10-Q · filed 2016-08-08 | -$2.98M 10-Q · filed 2016-08-08 | |||||
| 2016-03-31 | -$2.79M 10-Q · filed 2016-05-02 | ||||||
| 2015-09-30 | -$2.96M 10-Q · filed 2015-11-02 | -$4.94M derived: sum of 2 quarters · filed 2016-08-08 | -$779.00K 10-Q · filed 2015-11-02 | -$5.03M derived: sum of 4 quarters · filed 2016-08-08 | |||
| 2015-06-30 | -$1.98M 10-Q · filed 2016-08-08 | $2.18M 10-Q · filed 2016-08-08 | -$2.07M derived: sum of 3 quarters · filed 2016-08-08 | $3.15M derived: sum of 4 quarters · filed 2016-08-08 | |||
| 2015-03-31 | $4.16M 10-Q · filed 2016-05-02 | -$89.00K derived: sum of 2 quarters · filed 2016-05-02 | $5.13M derived: sum of 3 quarters · filed 2016-05-02 | $6.65M derived: sum of 4 quarters · filed 2016-05-02 | |||
| 2014-12-31 | -$4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $968.00K derived: sum of 2 quarters · filed 2015-11-02 | $2.49M derived: sum of 3 quarters · filed 2015-11-02 | $3.78M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $5.22M 10-Q · filed 2015-11-02 | -$5.22M 10-Q · filed 2014-10-28 | $6.74M derived: sum of 2 quarters · filed 2015-11-02 | $8.03M 10-Q · filed 2015-11-02 | -$8.03M 10-Q · filed 2014-10-28 | $16.27M derived: sum of 4 quarters · filed 2015-11-02 | |
| 2014-06-30 | $1.52M 10-Q · filed 2015-08-05 | -$1.52M 10-Q · filed 2014-07-31 | $2.81M 10-Q · filed 2015-08-05 | -$2.81M 10-Q · filed 2014-07-31 | $11.06M derived: sum of 3 quarters · filed 2015-08-05 | $6.91M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | $1.29M 10-Q · filed 2015-05-05 | -$1.29M 10-Q · filed 2014-05-02 | $9.53M derived: sum of 2 quarters · filed 2015-05-05 | $5.39M derived: sum of 3 quarters · filed 2015-05-05 | $4.69M derived: sum of 4 quarters · filed 2015-05-05 | ||
| 2013-12-31 | $8.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $4.10M derived: sum of 2 quarters · filed 2015-03-02 | $3.40M derived: sum of 3 quarters · filed 2015-03-02 | $2.72M 10-K · filed 2015-03-02 | |||
| 2013-09-30 | -$4.15M 10-Q · filed 2014-10-28 | -$4.85M derived: sum of 2 quarters · filed 2014-10-28 | -$5.53M 10-Q · filed 2014-10-28 | ||||
| 2013-06-30 | -$698.00K 10-Q · filed 2014-07-31 | -$1.38M 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | -$682.00K 10-Q · filed 2014-05-02 | ||||||
| 2011-12-31 | $3.10M 10-K · filed 2012-02-22 | ||||||
| 2011-09-30 | $400.00K 10-Q · filed 2011-10-31 | ||||||
| 2011-06-30 | $400.00K 10-Q · filed 2011-08-01 | ||||||
| 2010-12-31 | $400.00K 10-Q · filed 2011-10-31 | $400.00K 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |